Publications by authors named "David Osoba"

Claim this Profile
C
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
Andrew J Song, Keyue Ding, Iyad Alnahhas, Normand J Laperriere, James Perry, David Osoba

Neurooncol Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trial.
Andrew J Song, Keyue Ding, Iyad Alnahhas, Normand J Laperriere, James Perry, David Osoba

Neurooncol Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
James R Perry, Normand Laperriere, Christopher J O'Callaghan, Alba A Brandes, Johan Menten, David Osoba

N Engl J Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
Chantal Quinten, Francesca Martinelli, Corneel Coens, Mirjam A G Sprangers, Jolie Ringash, David Osoba

Cancer· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Chantal Quinten, John Maringwa, Carolyn C Gotay, Francesca Martinelli, Corneel Coens, David Osoba

J Natl Cancer Inst· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
John T Maringwa, Chantal Quinten, Madeleine King, Jolie Ringash, David Osoba

Support Care Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Francesca Martinelli, Chantal Quinten, John T Maringwa, Corneel Coens, Jurgen Vercauteren, David Osoba

Expert Rev Pharmacoecon Outcomes Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and cancer clinical trials.
David Osoba

Ther Adv Med Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire.
Madeleine T King, David Cella, David Osoba, Martin Stockler, David Eton

Patient Relat Outcome Meas· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
Martin J B Taphoorn, Lily Claassens, Neil K Aaronson, Corneel Coens, Murielle Mauer, David Osoba

Eur J Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G.
Madeleine T King, Martin R Stockler, David F Cella, David Osoba, David T Eton

J Clin Epidemiol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
Chantal Quinten, Corneel Coens, Murielle Mauer, Sylvie Comte, Mirjam A G Sprangers, David Osoba

Lancet Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative.
Andrew Bottomley, Chantal Quinten, Corneel Coens, Francesca Martinelli, Murielle Mauer, David Osoba

Eur J Cancer Care (Engl)· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating the science of patient-reported outcomes assessment into clinical practice.
David Osoba

J Natl Cancer Inst Monogr· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience.
David Osoba, Andrea Bezjak, Michael Brundage, Joseph Pater,

Value Health· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.
Michael Brundage, David Osoba, Andrea Bezjak, Dongsheng Tu, Michael Palmer

J Clin Oncol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and predicting survival in cancer: not a simple matter.
David Osoba

Support Care Cancer· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment.
David Osoba, Ming-Ann Hsu, Catherine Copley-Merriman, John Coombs, F Reed Johnson

Qual Life Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach.
F Reed Johnson, A Brett Hauber, David Osoba, Ming-Ann Hsu, John Coombs

Qual Life Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
Martin J B Taphoorn, Roger Stupp, Corneel Coens, David Osoba, Rolf Kortmann

Lancet Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.
Steven M Grunberg, David Osoba, Paul J Hesketh, Richard J Gralla, Sussanne Borjeson

Support Care Cancer· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emesis induced by low or minimal emetic risk chemotherapy.
Maurizio Tonato, Rebecca A Clark-Snow, David Osoba, Albano Del Favero, Enzo Ballatori

Support Care Cancer· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group.
David Osoba, Andrea Bezjak, Michael Brundage, Benny Zee, Dongsheng Tu

Eur J Cancer· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of liposomal anthracyclines in Kaposi's sarcoma.
Susan E Krown, Donald W Northfelt, David Osoba, J Simon Stewart

Semin Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study.
Andrea Bezjak, Dongsheng Tu, Monica Bacon, David Osoba, Benny Zee

J Clin Oncol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis